Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 3/20 | 0.79 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.79 |
| ▸ | LMNA | P02545 | 2/20 | 0.79 |
| ▸ | MAPT | P10636 | 1/20 | 0.79 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.66 |
| ▸ | NPC1 | O15118 | 4/20 | 0.63 |
| ▸ | HTT | P42858 | 2/20 | 0.63 |
| ▸ | F2R | P25116 | 1/20 | 0.63 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.59 |
| ▸ | HPGD | P15428 | 5/20 | 0.58 |
| ▸ | RAB9A | P51151 | 5/20 | 0.58 |
| ▸ | CRHBP | P24387 | 1/20 | 0.58 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.58 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.56 |
| ▸ | GAA | P10253 | 1/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7565149 | 0.95 | MAPK1 (0.81) | MAPK1HSD17B10LMNAMAPTALDH1A1 | |
| SCHEMBL7564877 | 0.89 | HPGD (0.71) | MAPK1HSD17B10LMNAMAPTALDH1A1 | |
| SCHEMBL9479621 | 0.87 | MAPK1 (0.97) | MAPK1HSD17B10LMNAMAPTALDH1A1 | |
| SCHEMBL21349100 | 0.87 | MAPK1 (0.66) | MAPK1HSD17B10LMNAMAPTALDH1A1 | |
| SCHEMBL9721920 | 0.87 | LMNA (0.62) | MAPK1HSD17B10LMNAMAPTALDH1A1 | |
| SCHEMBL3424143 | 0.86 | MAPK1 (0.69) | MAPK1HSD17B10LMNAMAPTALDH1A1 | |
| SCHEMBL11413462 | 0.86 | MAPK1 (0.74) | MAPK1HSD17B10LMNAMAPTALDH1A1 | |
| SCHEMBL7565917 | 0.86 | RAB9A (0.72) | MAPK1HSD17B10LMNAMAPTALDH1A1 | |
| SCHEMBL4108576 | 0.86 | MAPK1 (0.74) | MAPK1HSD17B10LMNAMAPTALDH1A1 | |
| SCHEMBL7565512 | 0.85 | RAB9A (0.70) | MAPK1HSD17B10LMNAMAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8017143-B2 | Coating agent for drug releasing stent, preparation method thereof and drug releasing stent coated therewith | TAEWOONG MEDICAL CO., LTD (KR) | 2011-09-13 | — | — | US | disclosed |
| US-20080300296-A1 | Coating agent for drug releasing stent, preparation method thereof and drug releasing stent coated therewith | TAEWOONG MEDICAL CO., LTD. | 2008-12-04 | — | — | US | disclosed |
| EP-0855393-B1 | BISBENZOTRIAZOLYLPHENOLS | OTSUKA KAGAKU KK (JP) | 2002-08-14 | — | — | EP | disclosed |
| US-5922882-A | ULTRAVIOLET RADIATION ABSORBER; COPOLYMERIZATION COMPONENT OF BISBENZOTRIAZOLE COMPRISING A COPOLYCARBONATE, A COPOLYESTER, A COPOLYURETHANE AND A COPOLYURETHANEURA | OTSUKA KAGAKU KABUSHIKI KAISHA (JP) | 1999-07-13 | — | — | US | disclosed |
| EP-0855393-A1 | BISBENZOTRIAZOLYLPHENOLS | OTSUKA KAGAKU KABUSHIKI KAISHA (JP) | 1998-07-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080300296-A1 | Coating agent for drug releasing stent, preparation method thereof and drug releasing stent coated therewith | SEM1, TGFB1, ABCB11 | MAPK1 346/4885HSD17B10 3091/4885LMNA 2824/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.